Several animal studies showed the AAPD-induced dyslipidemia is caused by weight gain and stimulation of appetite, presumably mediated through the antagonistic effects on hypothalamic serotonin 5HT2C and histamine H1 receptors (He et al., 2014). This evidence concerns the gene HTR2C and metabolic syndrome.